866-997-4948(US-Canada Toll Free)

Europe Transdermal Drug Delivery System Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 125 Pages

Notes:
Sales, means the sales volume of Transdermal Drug Delivery System
Revenue, means the sales value of Transdermal Drug Delivery System

This report studies sales (consumption) of Transdermal Drug Delivery System in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Novartis AG
Johnson & Johnson
Mylan Pharmaceuticals, Inc
Boehringer Ingelheim GmbH
Biogel Technology, Inc.
Transdermal Technologies, Inc.
Skyepharma PLC
Watson Pharmaceuticals, Inc
3M Company
Noven Pharmaceuticals, Inc
4P Therapeutics, LLC
Echo Therapeutics, Inc
Transdermal Corp

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Transdermal Drug Delivery System in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Electroporation
Radiofrequency
Iontophoresis
Microporation
Other

Split by application, this report focuses on sales, market share and growth rate of Transdermal Drug Delivery System in each application, can be divided into
Central Nervous System (CNS)
Pain Management
Cardiovascular
Other

Table of Contents

Europe Transdermal Drug Delivery System Market Report 2017
1 Transdermal Drug Delivery System Overview
1.1 Product Overview and Scope of Transdermal Drug Delivery System
1.2 Classification of Transdermal Drug Delivery System
1.2.1 Electroporation
1.2.2 Radiofrequency
1.2.3 Iontophoresis
1.2.4 Microporation
1.2.5 Other
1.3 Application of Transdermal Drug Delivery System
1.3.1 Central Nervous System (CNS)
1.3.2 Pain Management
1.3.3 Cardiovascular
1.3.4 Other
1.4 Transdermal Drug Delivery System Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Transdermal Drug Delivery System (2011-2021)
1.5.1 Europe Transdermal Drug Delivery System Sales and Growth Rate (2011-2021)
1.5.2 Europe Transdermal Drug Delivery System Revenue and Growth Rate (2011-2021)

2 Europe Transdermal Drug Delivery System by Manufacturers, Type and Application
2.1 Europe Transdermal Drug Delivery System Market Competition by Manufacturers
2.1.1 Europe Transdermal Drug Delivery System Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Transdermal Drug Delivery System Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Transdermal Drug Delivery System (Volume and Value) by Type
2.2.1 Europe Transdermal Drug Delivery System Sales and Market Share by Type (2011-2016)
2.2.2 Europe Transdermal Drug Delivery System Revenue and Market Share by Type (2011-2016)
2.3 Europe Transdermal Drug Delivery System (Volume and Value) by Countries
2.3.1 Europe Transdermal Drug Delivery System Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Transdermal Drug Delivery System Revenue and Market Share by Countries (2011-2016)
2.4 Europe Transdermal Drug Delivery System (Volume) by Application

3 Germany Transdermal Drug Delivery System (Volume, Value and Sales Price)
3.1 Germany Transdermal Drug Delivery System Sales and Value (2011-2016)
3.1.1 Germany Transdermal Drug Delivery System Sales and Growth Rate (2011-2016)
3.1.2 Germany Transdermal Drug Delivery System Revenue and Growth Rate (2011-2016)
3.1.3 Germany Transdermal Drug Delivery System Sales Price Trend (2011-2016)
3.2 Germany Transdermal Drug Delivery System Sales and Market Share by Manufacturers
3.3 Germany Transdermal Drug Delivery System Sales and Market Share by Type
3.4 Germany Transdermal Drug Delivery System Sales and Market Share by Application

4 France Transdermal Drug Delivery System (Volume, Value and Sales Price)
4.1 France Transdermal Drug Delivery System Sales and Value (2011-2016)
4.1.1 France Transdermal Drug Delivery System Sales and Growth Rate (2011-2016)
4.1.2 France Transdermal Drug Delivery System Revenue and Growth Rate (2011-2016)
4.1.4 France Transdermal Drug Delivery System Sales Price Trend (2011-2016)
4.2 France Transdermal Drug Delivery System Sales and Market Share by Manufacturers
4.3 France Transdermal Drug Delivery System Sales and Market Share by Type
4.4 France Transdermal Drug Delivery System Sales and Market Share by Application

5 UK Transdermal Drug Delivery System (Volume, Value and Sales Price)
5.1 UK Transdermal Drug Delivery System Sales and Value (2011-2016)
5.1.1 UK Transdermal Drug Delivery System Sales and Growth Rate (2011-2016)
5.1.2 UK Transdermal Drug Delivery System Revenue and Growth Rate (2011-2016)
5.1.5 UK Transdermal Drug Delivery System Sales Price Trend (2011-2016)
5.2 UK Transdermal Drug Delivery System Sales and Market Share by Manufacturers
5.3 UK Transdermal Drug Delivery System Sales and Market Share by Type
5.4 UK Transdermal Drug Delivery System Sales and Market Share by Application

6 Russia Transdermal Drug Delivery System (Volume, Value and Sales Price)
6.1 Russia Transdermal Drug Delivery System Sales and Value (2011-2016)
6.1.1 Russia Transdermal Drug Delivery System Sales and Growth Rate (2011-2016)
6.1.2 Russia Transdermal Drug Delivery System Revenue and Growth Rate (2011-2016)
6.1.6 Russia Transdermal Drug Delivery System Sales Price Trend (2011-2016)
6.2 Russia Transdermal Drug Delivery System Sales and Market Share by Manufacturers
6.3 Russia Transdermal Drug Delivery System Sales and Market Share by Type
6.4 Russia Transdermal Drug Delivery System Sales and Market Share by Application

7 Italy Transdermal Drug Delivery System (Volume, Value and Sales Price)
7.1 Italy Transdermal Drug Delivery System Sales and Value (2011-2016)
7.1.1 Italy Transdermal Drug Delivery System Sales and Growth Rate (2011-2016)
7.1.2 Italy Transdermal Drug Delivery System Revenue and Growth Rate (2011-2016)
7.1.7 Italy Transdermal Drug Delivery System Sales Price Trend (2011-2016)
7.2 Italy Transdermal Drug Delivery System Sales and Market Share by Manufacturers
7.3 Italy Transdermal Drug Delivery System Sales and Market Share by Type
7.4 Italy Transdermal Drug Delivery System Sales and Market Share by Application

8 Spain Transdermal Drug Delivery System (Volume, Value and Sales Price)
8.1 Spain Transdermal Drug Delivery System Sales and Value (2011-2016)
8.1.1 Spain Transdermal Drug Delivery System Sales and Growth Rate (2011-2016)
8.1.2 Spain Transdermal Drug Delivery System Revenue and Growth Rate (2011-2016)
8.1.8 Spain Transdermal Drug Delivery System Sales Price Trend (2011-2016)
8.2 Spain Transdermal Drug Delivery System Sales and Market Share by Manufacturers
8.3 Spain Transdermal Drug Delivery System Sales and Market Share by Type
8.4 Spain Transdermal Drug Delivery System Sales and Market Share by Application

9 Benelux Transdermal Drug Delivery System (Volume, Value and Sales Price)
9.1 Benelux Transdermal Drug Delivery System Sales and Value (2011-2016)
9.1.1 Benelux Transdermal Drug Delivery System Sales and Growth Rate (2011-2016)
9.1.2 Benelux Transdermal Drug Delivery System Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Transdermal Drug Delivery System Sales Price Trend (2011-2016)
9.2 Benelux Transdermal Drug Delivery System Sales and Market Share by Manufacturers
9.3 Benelux Transdermal Drug Delivery System Sales and Market Share by Type
9.4 Benelux Transdermal Drug Delivery System Sales and Market Share by Application

10 Europe Transdermal Drug Delivery System Manufacturers Analysis
10.1 Novartis AG
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Transdermal Drug Delivery System Product Type, Application and Specification
10.1.2.1 Electroporation
10.1.2.2 Radiofrequency
10.1.3 Novartis AG Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Johnson & Johnson
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Transdermal Drug Delivery System Product Type, Application and Specification
10.2.2.1 Electroporation
10.2.2.2 Radiofrequency
10.2.3 Johnson & Johnson Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Mylan Pharmaceuticals, Inc
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Transdermal Drug Delivery System Product Type, Application and Specification
10.3.2.1 Electroporation
10.3.2.2 Radiofrequency
10.3.3 Mylan Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Boehringer Ingelheim GmbH
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Transdermal Drug Delivery System Product Type, Application and Specification
10.4.2.1 Electroporation
10.4.2.2 Radiofrequency
10.4.3 Boehringer Ingelheim GmbH Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Biogel Technology, Inc.
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Transdermal Drug Delivery System Product Type, Application and Specification
10.5.2.1 Electroporation
10.5.2.2 Radiofrequency
10.5.3 Biogel Technology, Inc. Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Transdermal Technologies, Inc.
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Transdermal Drug Delivery System Product Type, Application and Specification
10.6.2.1 Electroporation
10.6.2.2 Radiofrequency
10.6.3 Transdermal Technologies, Inc. Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Skyepharma PLC
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Transdermal Drug Delivery System Product Type, Application and Specification
10.7.2.1 Electroporation
10.7.2.2 Radiofrequency
10.7.3 Skyepharma PLC Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Watson Pharmaceuticals, Inc
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Transdermal Drug Delivery System Product Type, Application and Specification
10.8.2.1 Electroporation
10.8.2.2 Radiofrequency
10.8.3 Watson Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 3M Company
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Transdermal Drug Delivery System Product Type, Application and Specification
10.9.2.1 Electroporation
10.9.2.2 Radiofrequency
10.9.3 3M Company Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Noven Pharmaceuticals, Inc
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Transdermal Drug Delivery System Product Type, Application and Specification
10.10.2.1 Electroporation
10.10.2.2 Radiofrequency
10.10.3 Noven Pharmaceuticals, Inc Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 4P Therapeutics, LLC
10.12 Echo Therapeutics, Inc
10.13 Transdermal Corp

11 Transdermal Drug Delivery System Manufacturing Cost Analysis
11.1 Transdermal Drug Delivery System Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Transdermal Drug Delivery System

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Transdermal Drug Delivery System Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Transdermal Drug Delivery System Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Transdermal Drug Delivery System Market Forecast (2016-2021)
14.1 Germany Transdermal Drug Delivery System Sales Forecast (2016-2021)
14.2 France Transdermal Drug Delivery System Sales Forecast (2016-2021)
14.3 UK Transdermal Drug Delivery System Sales Forecast (2016-2021)
14.4 Russia Transdermal Drug Delivery System Sales Forecast (2016-2021)
14.5 Italy Transdermal Drug Delivery System Sales Forecast (2016-2021)
14.6 Spain Transdermal Drug Delivery System Sales Forecast (2016-2021)
14.7 Benelux Transdermal Drug Delivery System Sales Forecast (2016-2021)
14.8 Europe Transdermal Drug Delivery System Sales Forecast by Type (2016-2021)
14.9 Europe Transdermal Drug Delivery System Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *